Synthesis and characterization of a novel organic nitrate NDHP: Role of xanthine oxidoreductase-mediated nitric oxide formation

Redox Biol. 2017 Oct:13:163-169. doi: 10.1016/j.redox.2017.05.014. Epub 2017 May 26.

Abstract

In this report, we describe the synthesis and characterization of 1,3-bis(hexyloxy)propan-2-yl nitrate (NDHP), a novel organic mono nitrate. Using purified xanthine oxidoreductase (XOR), chemiluminescence and electron paramagnetic resonance (EPR) spectroscopy, we found that XOR catalyzes nitric oxide (NO) generation from NDHP under anaerobic conditions, and that thiols are not involved or required in this process. Further mechanistic studies revealed that NDHP could be reduced to NO at both the FAD and the molybdenum sites of XOR, but that the FAD site required an unoccupied molybdenum site. Conversely, the molybdenum site was able to reduce NDHP independently of an active FAD site. Moreover, using isolated vessels in a myograph, we demonstrate that NDHP dilates pre-constricted mesenteric arteries from rats and mice. These effects were diminished when XOR was blocked using the selective inhibitor febuxostat. Finally, we demonstrate that NDHP, in contrast to glyceryl trinitrate (GTN), is not subject to development of tolerance in isolated mesenteric arteries.

Keywords: Nitrate; Nitric oxide; Nitrite; Organic nitrates; Tolerance; Xanthine oxidoreductase.

MeSH terms

  • Animals
  • Electron Spin Resonance Spectroscopy
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / physiology
  • Mice
  • Mice, Inbred C57BL
  • Muscle Contraction
  • Nitric Oxide / chemistry
  • Nitric Oxide / metabolism*
  • Nitro Compounds / chemical synthesis*
  • Nitro Compounds / chemistry
  • Nitro Compounds / pharmacology
  • Rats
  • Vasodilator Agents / chemical synthesis*
  • Vasodilator Agents / chemistry
  • Vasodilator Agents / pharmacology
  • Xanthine Dehydrogenase / chemistry
  • Xanthine Dehydrogenase / metabolism*

Substances

  • 1,3-bis(hexyloxy)propan-2-yl nitrate
  • Nitro Compounds
  • Vasodilator Agents
  • Nitric Oxide
  • Xanthine Dehydrogenase